Ind-Swift Limited (ISL), an Indian pharmaceutical group, said that it has rolled out its finished dosages products in Qatar as part of expanding its presence in the markets of Gulf Cooperation Council (GCC) countries. Presently in the UAE, Ind-Swift has a total of six products, including line extensions, which are marketed by a dedicated team […]
ANG Lifesciences India said that it has acquired two formulation manufacturing facilities in Baddi, Himachal Pradesh from Ind-Swift Limited for INR 60 crores. The acquired plants are now operating as Unit 5 and Unit 6 of ANG Lifesciences India and will help scale the company’s manufacturing capacity to handle the increasing demand from the domestic […]